Mengling Liu

Pharmacokinetics, Mass Balance, and Metabolism of the Novel Urate Transporter 1 Inhibitor [14C]HR011303 in Humans: Metabolism Is Mediated Predominantly by UDP-Glucuronosyltransferase

D. Zhong, L. Miao, Yan Zhan, 2021, Drug Metabolism and Disposition.

Site-specific protein modification by 3-n-butylphthalide in primary hepatocytes: Covalent protein adducts diminished by glutathione and N-acetylcysteine.

D. Zhong, Yaru Xue, X. Diao, 2021, Life sciences.

Mechanistic Study on the Species Differences in Excretion Pathway of HR011303 in Humans and Rats

Xiaoyan Chen, D. Zhong, Yaru Xue, 2021, Drug Metabolism and Disposition.

Absorption, distribution, metabolism, and excretion of [14C]Mefuparib (CVL218), a novel PARP1/2 inhibitor, in rats

C. Yang, Yifan Zhang, Yuandong Zheng, 2022, Cancer Chemotherapy and Pharmacology.

Pharmacokinetics, Mass Balance, and Metabolism of the Novel URAT1 Inhibitor in Humans: Metabolism is Mediated Predominantly by UDP-glucuronosyltransferase

L. Miao, Yan Zhan, Lin, 2021 .